FDA Gets U.S. One Step Closer to Interchangeable Biosimilars

May 15, 2019

Pharmacists are a step closer to seamlessly switching between a biologic drug and a cheaper alternative called a biosimilar thanks to final industry advice for drugmakers the Food and Drug Administration (FDA) released on May 10: Considerations in Demonstrating Interchangeability with a Reference Product (84 Fed. Reg. 21,342).